Education Library

Alexandra Lansky, MD, discusses a propensity-adjusted population-based analysis of Impella in patients undergoing high-risk PCI from a large-scale claims dataset. 

Srihari Naidu, MD discusses updates to the SCAI shock stages at TCT 2021.

Gregg Stone, MD, reviews evidence for the use of mechanical circulatory support during high-risk PCI and provides an overview of the PROTECT IV RCT.

Jason Wollmuth, MD, discusses large-bore access and intravascular imaging best practices for treating high-risk PCI patients.

Jeffrey Moses, MD, discusses the improved outcomes with contemporary practices seen in the PROTECT III study of Impella-supported high-risk PCI.

Navin Kapur, MD, explains the importance of identifying patients with heart failure who can be enrolled in the PROTECT IV trial.

William O’Neill, MD, discusses Protected PCI as a practical approach to mechanical circulatory support in elective complex PCI cases.

Jaime Hernandez-Montfort, MD, discusses management considerations for heart failure cardiogenic shock (HFCS) at HFSA 2021.

Navin Kapur, MD, discusses clinical evidence to support ‘on-pump’ complex PCI for patients with heart failure.

Shelley Hall, MD, discusses what can be done about cardiogenic shock and where the field is going, and issues a call for achieving heart recovery.

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

Cindy Grines, MD, presents data and clinical insights regarding complete revascularization and which patients might benefit from it.

Manreet Kanwar, MD, discusses the topic of heart recovery: How do we define it? How do we achieve it?

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

Daniel Goldstein, MD, discusses high-risk cardiac surgery from the STICH trial to a preview of the IMPACT trial that has received FDA IDE approval.